Feedback from the BIA members has been instrumental in shaping policies that affect access to skills and talent pathways for the UK bioscience industry. It provided insight into current challenges, barriers and opportunities for the sector and helped influence policymakers on the UK points-based immigration system (PBS).

Thanks to member evidence and positive actions, the BIA supported several submissions on Equality, Diversity and Inclusion (EDI), contributing to APPG on Equality in STEM and supplying evidence to the House of Commons Science and Technology Committee enquiry into diversity in STEM. We have also been part of the newly formed Medicines Manufacturing Challenge Fund EDI Community, led by Innovate UK, as part of a broader network of organisations sharing ideas and action plans to address EDI challenges.

If you would like to be part of this community, please get in touch with me at [email protected]

Map icon The UK's points-based immigration system: an introduction for employers

This guide provides an overview of the points-based immigration system and sets out the steps employers should take to adapt their business.

Books icon

BIA Guide to Immigration System

Here you will find an update about the UK points-based immigration system (PBS), routes, tiers and requirements summary.

Network icon

Migration Advisory Committee

The Migration Advisory Committee (MAC) is an independent, non-statutory, non-time limited, non-departmental public body that advises the government on migration issues.

Guidance icon

Guidance for businesses offering work to people coming from Ukraine

This publication provides guidance for companies considering making offers of employment to people coming to the UK from Ukraine.

Diversity and Inclusion in UK Biotech 

The Diversity and Inclusion in UK Biotech report is the first of its kind report based on a research study of 1,200 employees across 30 self-selected member organisations, representing a self-selected sample varying in size, investment stage and location. 

Diversity and Inclusion in UK Biotech